Oxurion
Manufacturing · Belgium · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gaston Geenslaan B-3001 1, Leuven, Fland...Phone Number
+32 16751310Website
www.oxurion.comRevenue
<$5 MillionStock Symbol
OXURIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Oxurion
Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration.Explore more
Oxurion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oxurion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Oxurion, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Oxurion
Funding: Get notified immidiatlly once Oxurion has new funding data
Product Launch: Get notified when Oxurion launches new products
Earning: See what the market has to say on Oxurion recently announced quarterly report
Check if Oxurion has recently received funding, and reach out quickly before it becomes old news!
Click to see if Oxurion had a recent Job posting/layoffs
Check out if Oxurion is spiking on competitors!
Recommended Actions
Find VP level buyers at Oxurion
Find 3 more new buyers
Company Profile Activity
Activity Insights
Oxurion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oxurion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oxurion.
Oxurion financials insights
Gather financial insights about Oxurion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Private Equity
$95.5M
2023
Other Financing Round
$21.7M
Debt
$2.2M
2025
Other Financing Round
$35M
Oxurion Tech Stack
A closer look at the technologies used by Oxurion
See more technologies
Most Recent Scoops
Funding
Funding
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
Financial Planning
Executive Move
Board of Directors
Executive Move
Board of Directors
Oxurion News & Media
Oxurion Secures EUR 30M for Diversification into Digital Assets - WebDisclosure
Oxurion NV reçoit une offre de financement de 30 millions d'euros d'Atlas Special Opportunities pour investir dans Bitcoin et Ethereum. Objectif de diversification de la trésorerieOxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on ...
Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane
Oxurion NV announces changes in Board of Directors with the departure of two members and the integration of Nelly Souleymane, strengthening governance and strategic expertise in communicationOxurion Nv : Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane
LEUVEN, BELGIUM - February 14, 2024 - 7:00PM, Oxurion NV , a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure of Ms. Anat Loewenstein...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oxurion
Sign Up For FreeTo access detailed company insights
Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration.... Read More
